AIA forces changes in invention capture and review procedures: study

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

AIA forces changes in invention capture and review procedures: study

The America Invents Act has prompted many companies to make changes in their invention capture and review procedures and public disclosure polices, according to a study released by IP advisory firm ipPerformance

Compared to study results released in 2012 before implementation of the AIA, roughly double the companies indicated that they made changes in invention capture and submission stage versus their preparation and filing stage.

Some 85% of companies indicated that the AIA has influenced them to make public disclosure of an invention prior to patent filing policy changes. A third of companies indicated that the increase in USPTO fees will cause an increase to their patent budget.

“America Invents Act has encouraged companies to adapt their procedures, workflows and policies. The increased fees as well as pre and post grant proceedings are major factors that are impacting budgeting and strategy,” said Robert Williamson, president at ipPerformance Group.

Fifty-nine companies representing a variety of industries participated in the study, including Air Liquide, Nova Chemical, Sun Chemical, Dow Corning Corporation, Nova Measuring Instruments, ZBD, Avebe, Sasol, Neste Oil, Micro Encoder, Automotive Technologies and Freescale Semiconductor.

more from across site and SHARED ros bottom lb

More from across our site

Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
The platform’s proactive intellectual property enforcement helps brands spot and kill fakes, so they can focus on growth. Managing IP learns more about the programme
Hire of José María del Valle Escalante to lead the firm’s operations in ‘dynamic’ Catalonia and Aragon regions follows last month’s appointment of a new chief information officer
Gift this article